North America Aortic Stent Graft Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2024-2032)

North America Aortic Stent Graft Market Outlook

The North America aortic stent graft market size was valued at USD 3.1 billion in 2023. It is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, driven by the growing geriatric population along with the advancements in stent graft materials and design in the region. It is estimated to reach a value of USD 5.2 billion by 2032.

Key Takeaways

• In the United States, ruptured abdominal aortic aneurysms are responsible for an estimated 15,000 deaths annually, ranking as the 13th leading cause of death in the region.

• In April 2023, Medtronic plc, declared positive results from a 10-year post-market ENGAGE registry for its Endurant stent graft system which provides endovascular aneurysm repair (EVAR) to treat the abdominal aortic aneurysm.

• In December 2023 , W. L. Gore & Associates, Inc. announced the first patient treatment with Gore ascending stent graft in the ARISE II study to treat pathologies involving the ascending aorta, marking an advancement in minimally invasive procedures.

An aortic stent graft is a tube consisting of fabric supported by a metal mesh and is commonly used to treat abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs). The rise in the prevalence of aortic aneurysms, characterized by the ballooning and weakening of the blood vessel, is expected to drive the North America aortic stent graft market demand. Recent data suggests that ruptured abdominal aortic aneurysms are responsible for an estimated 15,000 deaths annually in the United States, ranking as the 13th leading cause of death in the region. This indicates the need for innovative aortic stent graft products to tackle the rising burden of the disease and the associated mortality.

The market is witnessing increased investment in research and development activities by the key market players in order to meet the growing demand for improved and safer aortic stent grafts. In April 2023, Medtronic plc, an American medical device company, announced positive results from a 10-year post-market ENGAGE registry for its Endurant stent graft system which provides endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysm. The data was presented at the 2023 Charing Cross Symposium in London, revealing 94.7% of cases reporting freedom from aneurysm-related mortality out of a pool of 400 patients. The presence of such real-world patient evidence is likely to boost the trust of patients and healthcare providers in the efficacy of aortic stent grafts, thereby fuelling North America aortic stent graft market growth.

In December 2023 , W. L. Gore & Associates, Inc., an American multinational material science company, announced the first patient treatment with Gore ascending stent graft to treat pathologies involving the ascending aorta. It was based on the results of ARISE II, a pivotal study by the United States Food and Drug Administration (FDA). The study marks an advancement in minimally invasive procedures by using endovascular repair rather than conventional open surgical repair. The development of such minimally invasive alternatives which can reduce recovery times as well as the risk of complications is likely to augment the North America aortic stent graft market size in the forecast period.

The market is also driven by the rising technological innovation in stent grafts, the increased accessibility to novel medical devices in healthcare settings, and the growing elderly population at a greater risk of developing aortic aneurysms. Moreover, the presence of an advanced infrastructure and heightened patient awareness in the region is expected to bolster the market growth in the forecast period.

North America Aortic Stent Graft Market Segmentation

“North America Aortic Stent Graft Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:

North America Aortic Stent Graft Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Cook Medical, Inc.

• W.L. Gore & Associates

• MicroPort Scientific Corporation Inc.

• Medtronic Plc.

• Lombard Medical, Inc.

• Endologix, Inc.

• Terumo Corporation Inc.

• Cardinal Health Inc.

• Becton, Dickinson and Company

• Cryolife Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report